Skip to contentDEERFIELD CAPITAL LP — ALTIRIS INC insider: 259 transactions · InsiderLensDEERFIELD CAPITAL LP
- 10% owner at PAR PHARMACEUTICAL COMPANIES, INC. · on record since Feb 1, 2007
- 10% owner at DA32 Life Science Tech Acquisition Corp. · on record since Aug 1, 2023
- Director by Deputization at DA32 Life Science Tech Acquisition Corp. · on record since Aug 1, 2023
- 10% owner at Larimar Therapeutics, Inc. · on record since Feb 16, 2024
- * Director by Deputization at Larimar Therapeutics, Inc. · on record since Feb 16, 2024
- 10% owner at AdaptHealth Corp. · on record since Mar 12, 2024
- *Possible Member of 10% Group at AdaptHealth Corp. · on record since Mar 12, 2024
- 10% owner at Bicara Therapeutics Inc. · on record since Sep 17, 2024
- *Possible Member of 10% Group at Bicara Therapeutics Inc. · on record since Sep 12, 2024
- 10% owner at Nuvalent, Inc. · on record since Oct 24, 2024
- 10% owner at INSPIRE PHARMACEUTICALS INC · on record since May 2, 2007
- 10% owner at CORAUTUS GENETICS INC · on record since Aug 24, 2007
- 10% owner at DYNAVAX TECHNOLOGIES CORP · on record since Jul 23, 2007
- 10% owner at DUSA PHARMACEUTICALS INC · on record since Nov 27, 2007
- 10% owner at EMAGEON INC · on record since Nov 27, 2007
- 10% owner at ANADYS PHARMACEUTICALS INC · on record since Oct 25, 2007
- 10% owner at ARENA PHARMACEUTICALS INC · on record since Oct 23, 2007
- 10% owner at NeurogesX Inc · on record since Mar 31, 2008
- 10% owner at XCYTE THERAPIES INC · on record since Mar 14, 2008
- Director by Deputization at Nuvalent, Inc. · on record since Oct 24, 2024
- 10% owner at NITROMED INC · on record since May 6, 2008
- 10% owner at SALIX PHARMACEUTICALS LTD · on record since Oct 21, 2008
- 10% owner at NeuroMetrix, Inc. · on record since Dec 5, 2008
- 10% owner at NxStage Medical, Inc. · on record since Jun 19, 2009
- 10% owner at FISCHER IMAGING CORP · on record since Aug 17, 2004
- Director at Q32 Bio Inc. · on record since Apr 4, 2018
- 10% owner at Aclaris Therapeutics, Inc. · on record since Dec 27, 2018
- Director at Oncology Institute, Inc. · on record since Mar 17, 2020
- Director at Deerfield Healthcare Technology Acquisitions Corp. · on record since Jul 22, 2020
- Director at Acutus Medical, Inc. · on record since Aug 12, 2020
- Director at Oncorus, Inc. · on record since Oct 8, 2020
- Director at DA32 Life Science Tech Acquisition Corp. · on record since Jul 27, 2021
- Director at Larimar Therapeutics, Inc. · on record since Sep 20, 2022
- Director at Nuvalent, Inc. · on record since Nov 7, 2022
Insider trading activity of DEERFIELD CAPITAL LP
- Transactions on record
- 259
- since Feb 24, 2006
- Open-market buys
- 98
- $174.8M
- Open-market sells
- 119
- $247.9M
- Companies traded
- 32
- last filing Oct 24, 2024
Figures computed from official regulatory filings — methodology.
Companies where DEERFIELD CAPITAL LP has traded
- Nuvalent, Inc.3 tx · $217.3M · Oct 24, 2024
- Larimar Therapeutics, Inc.12 tx · $39.1M · Feb 16, 2024
- Xilio Therapeutics, Inc.6 tx · $12.4M · Oct 28, 2021
- DA32 Life Science Tech Acquisition Corp.1 tx · Aug 9, 2021
- Deerfield Healthcare Technology Acquisitions Corp.1 tx · $33.6M · Jul 22, 2020
- Q32 Bio Inc.7 tx · $15.6M · Dec 23, 2019
- Korro Bio, Inc.5 tx · $4M · Oct 7, 2019
- Aclaris Therapeutics, Inc.2 tx · $7.7K · Jun 26, 2019
- Swav Enterprises Ltd.11 tx · $510K · Mar 11, 2019
Track record of DEERFIELD CAPITAL LP
Statistical track record
Free- Open-market buys
- 100
- Last buy
- Feb 16, 2024
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of DEERFIELD CAPITAL LP
Co-insiders of DEERFIELD CAPITAL LP
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
6 tx · $16M · May 31, 2018
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Oct 24, 2024 | Sell | -1,000,000 | 97.75 USD | $97.8M | SEC |
| Oct 24, 2024 | Sell | -1,000,000 | 97.75 USD | $97.8M | SEC |
| Feb 16, 2024 | Buy | 1,430,206 | 8.74 USD | $12.5M | SEC |
| Feb 16, 2024 | Buy | 1,430,206 | 8.74 USD | $12.5M | SEC |
| Feb 16, 2024 | Buy | 1,430,205 | 8.74 USD | $12.5M | SEC |
| Nov 7, 2022 | Buy | 650,000 | 33.50 USD | $21.8M | SEC |
| Oct 28, 2021 | Other | 756,472 | — | — | SEC |
| Oct 28, 2021 | Other | 756,472 | — | — | SEC |
| Oct 28, 2021 | OtherD | -7,186,489 | — | — | SEC |
| Oct 28, 2021 | Buy | 387,500 | 16.00 USD | $6.2M | SEC |
| Oct 28, 2021 | Buy | 387,500 | 16.00 USD | $6.2M | SEC |
| Oct 28, 2021 | OtherD | -7,186,489 | — | — | SEC |
| Aug 9, 2021 | OtherD | -701,250 | 0.00 USD | $0 | SEC |
| Jul 22, 2020 | Other | 3,360,000 | 10.00 USD | $33.6M | SEC |
| Dec 23, 2019 | Sell | -56,595 | 21.83 USD | $1.2M | SEC |
| Dec 23, 2019 | Sell | -7,168 | 21.68 USD | $155.4K | SEC |
| Dec 23, 2019 | Sell | -5,454 | 21.68 USD | $118.2K | SEC |
| Dec 23, 2019 | Sell | -11,999 | 21.50 USD | $258K | SEC |
| Dec 23, 2019 | Sell | -9,130 | 21.50 USD | $196.3K | SEC |
| Dec 23, 2019 | Sell | -74,384 | 21.83 USD | $1.6M | SEC |
| Oct 7, 2019 | OtherD | -3,184,948 | — | — | SEC |
| Oct 7, 2019 | Other | 472,860 | — | — | SEC |
| Oct 7, 2019 | Buy | 285,714 | 14.00 USD | $4M | SEC |
| Oct 7, 2019 | OtherD | -3,184,948 | — | — | SEC |
| Oct 7, 2019 | Other | 472,860 | — | — | SEC |